Knowledge Center
White Paper / May 08, 2026
Integrated Nasal Powder Development Platform
Source:
Hovione White Paper
Why are nasal powders finally having their moment?
Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways.
Related links
Also in the Knowledge Center
/ Oct 13, 2021
Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry
Read more
Scientific Article
/ Oct 18, 2021
Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release
Read more
Scientific Article
/ Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Read more
Scientific Article